Pancreatic Cancer Research

ResearcherUniversity of PittsburghActive in the last 2 years

Renee R. Anderko

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1964-3404; OpenAlex author ID A5006701443. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. Pancreatic Cancer Organoids Recapitulate Chemotherapy Response and Identify a Potent Cytotoxic T-Cell Population. Co-author DOI 10.1158/1078-0432.ccr-25-1110↗
  2. Combination therapy with immune agonists and senescence-inducing agents delivers promise for immunotherapeutic success in pancreatic cancer. Co-author DOI 10.1093/jleuko/qiae234↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Amer H. Zureikat · 2 shared papers, 2025–2026 · strength 0.69
  2. Tullia Carmela Bruno · 1 shared paper, 2025 · strength 0.42
  3. Pranav Murthy · 1 shared paper, 2026 · strength 0.26
  4. Asmita Chopra · 1 shared paper, 2026 · strength 0.26
  5. Sebastiaan Ceuppens · 1 shared paper, 2026 · strength 0.26
  6. Michael T. Lotze · 1 shared paper, 2026 · strength 0.26
  7. Aatur Dilip Singhi · 1 shared paper, 2026 · strength 0.26
  8. Alessandro Paniccia · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.